HHLR ADVISORS, LTD.
Institutional investor · Portfolio as of Q1 2020
Top Holdings60 positions
Zoom Video Communications Inc | 6.2M | $905.1M | 12.2% | $66.79 | +125.90% | 2 qtrssince 2019-Q4 | Decreased 0 |
iQIYI Inc | 46.7M | $831.2M | 11.2% | $18.39 | +1.46% | 6 qtrssince 2018-Q4 | Unchanged 0 |
BEIGENE LTD | 5.5M | $673.7M | 9.1% | $136.90 | -10.07% | 6 qtrssince 2018-Q4 | Unchanged 0 |
Uber Technologies Inc | 19.3M | $537.8M | 7.2% | $29.72 | -6.36% | 3 qtrssince 2019-Q3 | Increased 74 |
JD.com Inc | 11.9M | $482.2M | 6.5% | $20.17 | +81.71% | 6 qtrssince 2018-Q4 | Unchanged 0 |
TAL EDUCATION GROUP- ADR | 7.5M | $399.7M | 5.4% | $30.74 | +69.18% | 6 qtrssince 2018-Q4 | Decreased 0 |
Alibaba Group Holding Ltd | 2M | $385M | 5.2% | $138.98 | +31.69% | 6 qtrssince 2018-Q4 | Unchanged 0 |
Pinduoduo Inc | 8.7M | $314.5M | 4.2% | $25.54 | +41.07% | 6 qtrssince 2018-Q4 | Unchanged 0 |
CHINA BIOLOGIC PRODS HLDGS I | 2.8M | $296.9M | 4.0% | — | — | 6 qtrssince 2018-Q4 | Unchanged 0 |
Enstar Group Ltd | 1.7M | $278M | 3.7% | — | — | 5 qtrssince 2019-Q1 | Unchanged 0 |
Bilibili Inc | 10.2M | $239.2M | 3.2% | $15.50 | +48.16% | 6 qtrssince 2018-Q4 | Unchanged 0 |
Align Technology Inc | 1.1M | $185.5M | 2.5% | $209.25 | -14.02% | 3 qtrssince 2019-Q3 | Decreased 0 |
VIELA BIO INC | 4.6M | $174.5M | 2.4% | — | — | 2 qtrssince 2019-Q4 | Unchanged 0 |
FibroGen Inc | 4M | $137.5M | 1.9% | — | — | — | Unchanged 0 |
BRIDGEBIO PHARMA INC | 4.7M | $136.6M | 1.8% | $23.99 | +11.15% | 4 qtrssince 2019-Q2 | Increased 51 |
Apellis Pharmaceuticals Inc | 5M | $134.7M | 1.8% | $19.43 | +47.64% | 6 qtrssince 2018-Q4 | Increased 51 |
Mondelez International Inc | 2.5M | $127.5M | 1.7% | $33.70 | +31.57% | 6 qtrssince 2018-Q4 | Unchanged 0 |
Vipshop Holdings Ltd | 7M | $109.8M | 1.5% | $14.06 | 0.00% | 1 qtr | New 69 |
Blueprint Medicines Corp | 1.6M | $94.3M | 1.3% | — | — | 6 qtrssince 2018-Q4 | Increased 51 |
ZTO Express Cayman Inc | 3.4M | $90.9M | 1.2% | $23.13 | 0.00% | 1 qtr | New 68 |
HHLR ADVISORS, LTD. manages $7.4B across 60 positions as of Q1 2020. Top holdings: ZM (12.2%), IQ (11.2%), ONC (9.1%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 2.5/5.0.
Active quarter - 9 new positions, 3 exits, 5 increased. Top move: UBER (INCREASED, conviction 74). Portfolio: $7.4B across 60 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR